Transplantation for Hepatocellular Carcinoma

Area of Science:

• Hepatology
• Surgical Oncology
• Transplant Medicine

Background:

• Hepatocellular carcinoma (HCC) is a significant global health concern.
• Liver transplantation is the sole curative option for select HCC patients.
• Effective management necessitates a structured approach to patient selection and care.

Purpose of the Study:

• To outline the critical steps for successful liver transplantation in HCC patients.
• To emphasize the importance of multidisciplinary evaluation and neoadjuvant therapy.
• To highlight the necessity of post-transplant surveillance for HCC recurrence.

Main Methods:

• Multidisciplinary team evaluation for HCC patient suitability.
• Application of neoadjuvant treatments (bridging or downstaging) to stabilize disease.
• Listing for liver transplantation following a minimum of 6 months of stable disease.
• Regular post-transplant surveillance protocols to monitor for recurrence.

Main Results:

• Careful patient selection and neoadjuvant therapy improve transplant outcomes for HCC.
• Achieving stable disease for 6 months is a key criterion for transplant listing.
• Post-transplant surveillance is crucial for early detection of HCC recurrence.

Conclusions:

• Liver transplantation is a vital curative strategy for HCC.
• A comprehensive, multidisciplinary approach encompassing evaluation, neoadjuvant treatment, and surveillance is essential for successful outcomes.
• Ongoing monitoring post-transplantation is critical for managing HCC recurrence.